Oireachtas Joint and Select Committees

Wednesday, 8 November 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion (Resumed)

See the whole debate « Previous speaker Next speaker »

9:00 am

Professor Michael Barry:

It is on managed access. However, it is possible that Britain made a mistake in that regard. If the FDA does not believe the drug works very well and it needs more data-----

Comments

No comments

 

Log in or join to post a public comment.